Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (201-210 of 975) with videos related to

Pageof 98
Sort By:
Annals of Diagnostic Pathology|April 30, 2015
Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variantJohanna D Strehl, David L Wachter, Jutta Fiedler, et al.
Frontiers in Immunology|March 3, 2022
Complement Activation <i>via</i> the Lectin and Alternative Pathway in Patients With Severe COVID-19Janina Niederreiter, Christine Eck, Tajana Ries, et al.
Medical Oncology (Northwood, London, England)|March 30, 2017
PD-L2: A prognostic marker in chromophobe renal cell carcinoma?Franziska Erlmeier, Wilko Weichert, Michael Autenrieth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2014
Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11Ross M Drayton, Ewa Dudziec, Stefan Peter, et al.
Annals of Translational Medicine|January 14, 2020
PD-L1 assessment in urothelial carcinoma: a practical approachMarkus Eckstein, Alessia Cimadamore, Arndt Hartmann, et al.
Histopathology|May 18, 2022
Primary pseudomyogenic haemangioendothelioma of the testis with a novel POTEI::FOSB gene fusionAnn-Kathrin Gersmann, Florian Haller, Nina Behnert, et al.
Pathology|July 8, 2008
Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcomeStefan Denzinger, Maximilian Burger, Christine G Hammerschmied, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
Clinical and Surgical Evaluation of Sentinel Node Biopsy in Patients with Early-Stage Endometrial Cancer and Atypical HyperplasiaPatrik Pöschke, Paul Gass, Annika Krückel, et al.
Frontiers in Immunology|October 9, 2023
Corrigendum: Complement activation via the lectin and alternative pathway in patients with severe COVID-19Janina Niederreiter, Christine Eck, Tajana Ries, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2014
Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypesAbbas Agaimy, Florian Haller, Judith Frohnauer, et al.
Pageof 98

Showing results (201-210 of 975) with videos related to

Sort By:
Pageof 98
Annals of Diagnostic Pathology|April 30, 2015
Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variantJohanna D Strehl, David L Wachter, Jutta Fiedler, et al.
Frontiers in Immunology|March 3, 2022
Complement Activation <i>via</i> the Lectin and Alternative Pathway in Patients With Severe COVID-19Janina Niederreiter, Christine Eck, Tajana Ries, et al.
Medical Oncology (Northwood, London, England)|March 30, 2017
PD-L2: A prognostic marker in chromophobe renal cell carcinoma?Franziska Erlmeier, Wilko Weichert, Michael Autenrieth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2014
Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11Ross M Drayton, Ewa Dudziec, Stefan Peter, et al.
Annals of Translational Medicine|January 14, 2020
PD-L1 assessment in urothelial carcinoma: a practical approachMarkus Eckstein, Alessia Cimadamore, Arndt Hartmann, et al.
Histopathology|May 18, 2022
Primary pseudomyogenic haemangioendothelioma of the testis with a novel POTEI::FOSB gene fusionAnn-Kathrin Gersmann, Florian Haller, Nina Behnert, et al.
Pathology|July 8, 2008
Pax-5 protein expression in bladder cancer: a preliminary study that shows no correlation to grade, stage or clinical outcomeStefan Denzinger, Maximilian Burger, Christine G Hammerschmied, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
Clinical and Surgical Evaluation of Sentinel Node Biopsy in Patients with Early-Stage Endometrial Cancer and Atypical HyperplasiaPatrik Pöschke, Paul Gass, Annika Krückel, et al.
Frontiers in Immunology|October 9, 2023
Corrigendum: Complement activation via the lectin and alternative pathway in patients with severe COVID-19Janina Niederreiter, Christine Eck, Tajana Ries, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 9, 2014
Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypesAbbas Agaimy, Florian Haller, Judith Frohnauer, et al.
Pageof 98